GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » IDEXX Laboratories Inc (NAS:IDXX) » Definitions » Price-to-Operating-Cash-Flow

IDXX (IDEXX Laboratories) Price-to-Operating-Cash-Flow : 35.19 (As of Oct. 31, 2024)


View and export this data going back to 1991. Start your Free Trial

What is IDEXX Laboratories Price-to-Operating-Cash-Flow?

As of today (2024-10-31), IDEXX Laboratories's share price is $406.92. IDEXX Laboratories's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2024 was $11.56. Hence, IDEXX Laboratories's Price-to-Operating-Cash-Flow Ratio for today is 35.19.

The historical rank and industry rank for IDEXX Laboratories's Price-to-Operating-Cash-Flow or its related term are showing as below:

IDXX' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 27.35   Med: 48.66   Max: 78.15
Current: 35.19

During the past 13 years, IDEXX Laboratories's highest Price-to-Operating-Cash-Flow Ratio was 78.15. The lowest was 27.35. And the median was 48.66.

IDXX's Price-to-Operating-Cash-Flow is ranked worse than
79.28% of 111 companies
in the Medical Diagnostics & Research industry
Industry Median: 18.03 vs IDXX: 35.19

IDEXX Laboratories's Cash Flow from Operations per share for the three months ended in Jun. 2024 was $2.98. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2024 was $11.56.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of IDEXX Laboratories was 30.10% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 13.00% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 15.70% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 17.10% per year.

During the past 13 years, IDEXX Laboratories's highest 3-Year average Operating Cash Flow per Share Growth Rate was 86.50% per year. The lowest was -6.80% per year. And the median was 16.30% per year.


IDEXX Laboratories Price-to-Operating-Cash-Flow Historical Data

The historical data trend for IDEXX Laboratories's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IDEXX Laboratories Price-to-Operating-Cash-Flow Chart

IDEXX Laboratories Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 49.79 66.89 75.45 63.56 51.42

IDEXX Laboratories Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 56.49 44.22 51.42 49.22 42.13

Competitive Comparison of IDEXX Laboratories's Price-to-Operating-Cash-Flow

For the Diagnostics & Research subindustry, IDEXX Laboratories's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IDEXX Laboratories's Price-to-Operating-Cash-Flow Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, IDEXX Laboratories's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where IDEXX Laboratories's Price-to-Operating-Cash-Flow falls into.



IDEXX Laboratories Price-to-Operating-Cash-Flow Calculation

IDEXX Laboratories's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=406.92/11.563
=35.19

IDEXX Laboratories's Share Price of today is $406.92.
IDEXX Laboratories's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $11.56.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

IDEXX Laboratories Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of IDEXX Laboratories's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


IDEXX Laboratories Business Description

Address
One IDEXX Drive, Westbrook, ME, USA, 04092
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.
Executives
M Anne Szostak director C/O TUPPERWARE BRANDS CORP, 14901 S ORANGE BLOSSOM TR, ORLANDO FL 32837
Bruce L. Claflin director 7035 RIDGE ROAD, HANOVER MD 21076
James F Polewaczyk officer: Corporate Vice President IDEXX LABORATORIES, INC., ONE IDEXX DRIVE, WESTBROOK ME 04092
Sophie V. Vandebroek director 6 OAK MEADOW ROAD, LINCOLN MA 01770
George Fennell officer: CORPORATE VICE PRESIDENT IDEXX LABORATORIES, INC., ONE IDEXX DRIVE, WESTBROOK ME 04092
Brian P Mckeon director IDEXX LABORATORIES, ONE IDEXX DRIVE, WESTBROOK ME 04092
Jonathan Jay Mazelsky director, officer: President and CEO ONE IDEXX DRIVE, WESTBROOK ME 04092
Martin Alexander Smith officer: Executive Vice President C/O IDEXX LABORATORIES, INC., ONE IDEXX DRIVE, WESTBROOK ME 04092
Jonathan W Ayers director, officer: President & CEO IDEXX LABORATORIES, INC., ONE IDEXX DRIVE, WESTBROOK ME 04092
Michael Lane officer: Executive Vice President C/O IDEXX LABORATORIES, INC., WESTBROOK ME 04092
Irene Chang Britt director CAMPBELL SOUP COMPANY, ONE CAMPBELL PLACE, CAMDEN NJ 08103
Samer Abdul Samad director 5200 ILLUMINA WAY, SAN DIEGO CA 92122
Lawrence D Kingsley director C/O IDEX CORPORATION, 630 DUNDEE ROAD, NORTHBROOK IL 60062
Asha Collins director IDEXX LABORATORIES, INC., ONE IDEXX DRIVE, WESTBROOK ME 04092
Stuart Essig director 311 C ENTERPRISE DRIVE, PLAINSBORO NJ 08536